Reporter Account  Create New Account  Login!
Search :
QUICK LINKS : Art & Entertainment Automotive Blogging & Social Media Business Computer Design Education Environment Events / Trade Shows  
Platform for Startups
Post Your Story for FREE!
Increase Sales in Just 69 secs!
Promote Your Events
For Press Release Writing
Press Release Details    
Add to Favorites  Mail to a Friend Print Page   Share This News Rate
Save This Listing     Stumble It          

MRIs May Make Prostate Cancer Screening More Definitive: Study

Founder of the renowned Prostate Seed Institute talks about the use of this simple imaging test.

Irving, TX, — Men who are suspected to have prostate cancer based on blood test and other screening results may benefit from a secondary MRI screen to confirm or deny the disease’s presence before they undergo biopsies. A recent study found significant benefit in adding this additional form of screening into the routine.

Researchers found that using an MRI in advance of a biopsy would help as many as 27 percent of men thought to have prostate cancer rule out this condition. This, in turn, could spare men from unnecessary, invasive biopsies. What’s more, the study found that MRIs were highly effective in identifying aggressive prostate cancer. In some cases, the MRI was even more effective than the most commonly used form of biopsy.

“The study’s findings are especially important in that they shed light on a way to make screenings more accurate before action is taken,” says Dr. Gregory Echt, founder and lead surgeon at the Prostate Seed Institute. “This can potentially spare men from unnecessary procedures while ensuring that those with aggressive forms of the disease receive necessary treatment.”

The study in question involved more than 600 men who were suspected to have prostate cancer based on prostate-specific antigen testing results or other screenings. The MRI ruled out prostate cancer in some cases and was found to have a 93 percent accurate discovery rate of aggressive prostate cancers. The most commonly used biopsy only found about half of the aggressive cancers in the study group.

“The study’s findings come at a time when researchers and doctors alike are working to strike a balance between the need for routine screening and the imperfections found in the PSA,” says Dr. Echt. “This secondary screen may someday be recommended to bridge the gap to ensure a higher degree of accuracy before invasive procedures like biopsies are performed.”

Men who are concerned about prostate cancer are strongly urged to talk to their doctors about their risks. Routine screening can lead to early detection and potentially lifesaving treatment.

About The Prostate Seed Institute
The Prostate Seed Institute is one of the country’s leading pioneers in prostate cancer treatment including prostate seed implementation, a fast and painless procedure that effectively treats prostate cancer in its earliest stages. With a team of oncology experts and a state-of-the-art facility, the Prostate Seed Institute provides prostate cancer patients with the most comprehensive treatment available. To see the Procedure Comparison Chart and learn more about the Prostate Seed InstituteCLICK HERE.  

Contact Information

  • Name: Gregory Echt

    Company: Prostate Seed Institute

    Telphone: +1-21-43792700 , -

    Address: 7415 Las Colinas Blvd. Suite100
    Irving, Texas, 75063